DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Abou-Alfa GK, Meyer T, Cheng A-L. et al.
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial.
J Clin Oncol 2018;
36 (04) 207
We do not assume any responsibility for the contents of the web pages of other providers.